Timothy P. Bender - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Microbiology Biology

52/119 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Upadhye A, Marshall M, Garmey JC, Bender TP, McNamara C. Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production. Journal of Visualized Experiments : Jove. PMID 32538902 DOI: 10.3791/61003  0.444
2019 Upadhye A, Srikakulapu P, Gonen A, Hendrikx S, Perry HM, Nguyen AT, McSkimming C, Marshall M, Garmey J, Taylor A, Bender TP, Tsimikas S, Holodick NE, Rothstein TL, Witztum JL, et al. Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked To Human Coronary Atherosclerosis. Circulation Research. PMID 31549940 DOI: 10.1161/Circresaha.119.315786  0.395
2019 Shikatani EA, Besla R, Ensan S, Upadhye A, Khyzha N, Li A, Emoto T, Chiu F, Degousee N, Moreau JM, Perry HM, Thayaparan D, Cheng HS, Pacheco S, Smyth D, ... ... Bender TP, et al. c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells. Cell Reports. 27: 2304-2312.e6. PMID 31116977 DOI: 10.1016/J.Celrep.2019.04.090  0.417
2019 Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, Hocker JD, Hawk NV, Kapoor V, Telford WG, Gurusamy D, Yu Z, Bhandoola A, Xue HH, ... ... Bender TP, et al. The transcription factor c-Myb regulates CD8 T cell stemness and antitumor immunity. Nature Immunology. 20: 337-349. PMID 30778251 DOI: 10.1038/S41590-018-0311-Z  0.436
2018 Fahl SP, Daamen AR, Crittenden RB, Bender TP. c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint. Journal of Immunology (Baltimore, Md. : 1950). PMID 29654210 DOI: 10.4049/Jimmunol.1302303  0.484
2018 Jayappa KD, Cios KJ, Gordon VL, Arora PC, Bender TP, Williams ME, Portell CA, Weber MJ. A Multi-Drug Tolerant Phenotype Is Induced By Diverse Microenvironmental Agonists in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Blood. 132: 4120-4120. DOI: 10.1182/Blood-2018-99-119521  0.371
2018 Jayappa KD, Portell CA, Gordon VL, Narla G, Bender TP, Williams ME, Weber MJ. Drug Combinations Co-Targeting Myeloid Cell Leukemia-1 (Mcl-1) Protein Can Overcome Microenvironmentally-Induced Multi-Drug Tolerance in Non-Hodgkin Lymphomas Blood. 132: 2649-2649. DOI: 10.1182/Blood-2018-99-116759  0.361
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 6. PMID 29206103 DOI: 10.7554/Elife.32497  0.401
2017 Jayappa KD, Portell CA, Gordon VL, Capaldo BJ, Bekiranov S, Axelrod MJ, Brett LK, Wulfkuhle JD, Gallagher RI, Petricoin EF, Bender TP, Williams ME, Weber MJ. Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL. Blood Advances. 1: 933-946. PMID 29034364 DOI: 10.1182/Bloodadvances.2016004176  0.337
2017 Ziembik MA, Bender TP, Larner JM, Brautigan DL. Functions of protein phosphatase-6 in NF-κB signaling and in lymphocytes. Biochemical Society Transactions. 45: 693-701. PMID 28620030 DOI: 10.1042/Bst20160169  0.322
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. Author response: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice Elife. DOI: 10.7554/Elife.32497.055  0.304
2017 Jayappa KD, Portell CA, Gordon VL, Bender TP, Williams ME, Weber MJ. Abstract 08: Soluble agonists in the in vivo macroenvironment generate phenotypic de novo resistance to BTK/Bcl-2 targeted therapies in diverse B-cell malignancies Clinical Cancer Research. 23: 8-8. DOI: 10.1158/1557-3265.Hemmal17-08  0.355
2016 Jayappa KD, Portell CA, Gordon VL, Capaldo BJ, Bekiranov S, Wulfkuhle JD, Gallagher RI, Petricoin EF, Bender TP, Williams ME, Weber MJ. Extrinsic Factors in the In Vivo Macroenvironment Generate Phenotypic Resistance to BTK/Bcl-2 Targeted Therapies in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Blood. 128: 754-754. DOI: 10.1182/Blood.V128.22.754.754  0.332
2015 Rosenfeld SM, Perry HM, Gonen A, Prohaska TA, Srikakulapu P, Grewal S, Das D, McSkimming C, Taylor AM, Tsimikas S, Bender TP, Witztum JL, McNamara CA. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis. Circulation Research. 117: e28-39. PMID 26082558 DOI: 10.1161/Circresaha.117.306044  0.392
2015 Jayappa KD, Portell CA, Gordon V, Williams ME, Petricoin EF, Bender TP, Weber MJ. Ligands That Mimic the Tissue Microenvironment of Replicating Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Protect Ex Vivo Patient Cell Samples from the Cytotoxicity of Combined Treatment with Ibrutinib and Venetoclax (ABT-199) Blood. 126: 448-448. DOI: 10.1182/Blood.V126.23.448.448  0.396
2013 Perry HM, Oldham SN, Fahl SP, Que X, Gonen A, Harmon DB, Tsimikas S, Witztum JL, Bender TP, McNamara CA. Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 2771-9. PMID 24115031 DOI: 10.1161/Atvbaha.113.302571  0.413
2012 Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Frontiers in Immunology. 3: 373. PMID 23248624 DOI: 10.3389/Fimmu.2012.00373  0.403
2012 Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 120: 4772-82. PMID 22993390 DOI: 10.1182/Blood-2012-04-427013  0.414
2012 Doran AC, Lipinski MJ, Oldham SN, Garmey JC, Campbell KA, Skaflen MD, Cutchins A, Lee DJ, Glover DK, Kelly KA, Galkina EV, Ley K, Witztum JL, Tsimikas S, Bender TP, et al. B-cell aortic homing and atheroprotection depend on Id3. Circulation Research. 110: e1-12. PMID 22034493 DOI: 10.1161/Circresaha.111.256438  0.381
2012 Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R, Hyslop T, Bender TP, Calabretta B. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia. 26: 644-53. PMID 21960247 DOI: 10.1038/Leu.2011.264  0.335
2011 Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. The Journal of Experimental Medicine. 208: 2717-31. PMID 22124110 DOI: 10.1084/Jem.20111386  0.338
2011 Matalová E, Buchtová M, Tucker AS, Bender TP, Jane?ková E, Lungová V, Balková S, Smarda J. Expression and characterization of c-Myb in prenatal odontogenesis. Development, Growth & Differentiation. 53: 793-803. PMID 21762405 DOI: 10.1111/J.1440-169X.2011.01287.X  0.401
2011 Gimferrer I, Hu T, Simmons A, Wang C, Souabni A, Busslinger M, Bender TP, Hernandez-Hoyos G, Alberola-Ila J. Regulation of GATA-3 expression during CD4 lineage differentiation. Journal of Immunology (Baltimore, Md. : 1950). 186: 3892-8. PMID 21357543 DOI: 10.4049/Jimmunol.1003505  0.421
2010 Bender TP. A new window on c-Myb function. Blood. 116: 1190-1. PMID 20798239 DOI: 10.1182/Blood-2010-06-287300  0.417
2010 Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nature Immunology. 11: 435-41. PMID 20383148 DOI: 10.1038/Ni.1865  0.595
2010 Yuan J, Crittenden RB, Bender TP. c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL. Journal of Immunology (Baltimore, Md. : 1950). 184: 2793-804. PMID 20142358 DOI: 10.4049/Jimmunol.0902846  0.639
2010 Trampont PC, Tosello-Trampont AC, Shen Y, Duley AK, Sutherland AE, Bender TP, Littman DR, Ravichandran KS. CXCR4 acts as a costimulator during thymic beta-selection. Nature Immunology. 11: 162-70. PMID 20010845 DOI: 10.1038/Ni.1830  0.632
2010 Waldron TJ, Soliera AR, Zhang Y, Martinez R, Hyslop T, Bender T, Calabretta B. Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1 Cancer Research. 70: 5061-5061. DOI: 10.1158/1538-7445.Am10-5061  0.405
2009 Smith E, von Vietinghoff S, Stark MA, Zarbock A, Sanders JM, Duley A, Rivera-Nieves J, Bender TP, Ley K. T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivo. Journal of Immunology (Baltimore, Md. : 1950). 183: 5685-93. PMID 19843951 DOI: 10.4049/Jimmunol.0900887  0.631
2009 Fahl SP, Crittenden RB, Allman D, Bender TP. c-Myb is required for pro-B cell differentiation. Journal of Immunology (Baltimore, Md. : 1950). 183: 5582-92. PMID 19843942 DOI: 10.4049/Jimmunol.0901187  0.476
2009 Giles AJ, Bender TP, Ravichandran KS. The adaptor protein Shc plays a key role during early B cell development. Journal of Immunology (Baltimore, Md. : 1950). 183: 5468-76. PMID 19828641 DOI: 10.4049/Jimmunol.0902344  0.433
2008 Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. Requirement of c-Myb for p210 BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis Blood. 111: 4771-4779. PMID 18227349 DOI: 10.1182/Blood-2007-08-105072  0.386
2006 Chen J, Kremer CS, Bender TP. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells. Oncogene. 25: 2758-72. PMID 16407849 DOI: 10.1038/Sj.Onc.1209295  0.402
2005 Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity. 23: 275-86. PMID 16169500 DOI: 10.1016/J.Immuni.2005.08.005  0.612
2004 Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development Nature Immunology. 5: 721-729. PMID 15195090 DOI: 10.1038/Ni1085  0.453
2002 Zhang L, Camerini V, Bender TP, Ravichandran KS. A nonredundant role for the adapter protein Shc in thymic T cell development. Nature Immunology. 3: 749-55. PMID 12101399 DOI: 10.1038/Ni820  0.443
2002 Chen J, Kremer CS, Bender TP. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state. Oncogene. 21: 1859-69. PMID 11896618 DOI: 10.1038/Sj.Onc.1205003  0.416
2002 Kulkarni MS, Daggett JL, Bender TP, Kuehl WM, Bergsagel PL, Williams ME. Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis. Leukemia. 16: 127-34. PMID 11840272 DOI: 10.1038/Sj.Leu.2402328  0.306
2001 Chen J, Bender TP. A novel system to identify Myb target promoters in friend murine erythroleukemia cells. Blood Cells, Molecules & Diseases. 27: 429-36. PMID 11500057 DOI: 10.1006/Bcmd.2001.0401  0.421
1999 Allen RD, Bender TP, Siu G. c-Myb is essential for early T cell development. Genes & Development. 13: 1073-8. PMID 10323859 DOI: 10.1101/Gad.13.9.1073  0.427
1999 Müller C, Yang R, Idos G, Tidow N, Diederichs S, Koch OM, Verbeek W, Bender TP, Koeffler HP. c-myb Transactivates the Human Cyclin A1 Promoter and Induces Cyclin A1 Gene Expression Blood. 94: 4255-4262. DOI: 10.1182/Blood.V94.12.4255.424K32_4255_4262  0.397
1998 Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology. 139: 4164-74. PMID 9751496 DOI: 10.1210/Endo.139.10.6229  0.351
1996 Miglarese MR, Richardson AF, Aziz N, Bender TP. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain. The Journal of Biological Chemistry. 271: 22697-705. PMID 8798443 DOI: 10.1074/Jbc.271.37.22697  0.342
1995 Toth CR, Hostutler RF, Baldwin AS, Bender TP. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. The Journal of Biological Chemistry. 270: 7661-71. PMID 7706314 DOI: 10.1074/Jbc.270.13.7661  0.382
1995 Aziz N, Miglarese MR, Hendrickson RC, Shabanowitz J, Sturgill TW, Hunt DF, Bender TP. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proceedings of the National Academy of Sciences of the United States of America. 92: 6429-33. PMID 7604007 DOI: 10.1073/Pnas.92.14.6429  0.326
1993 Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM. Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells. Molecular and Cellular Biology. 13: 3505-13. PMID 8497265 DOI: 10.1128/mcb.13.6.3505-3513.1993  0.364
1991 Isakson PC, Purkerson J, Catron K, Bender TP. A novel method for synchronizing a B cell lymphoma. Journal of Immunological Methods. 145: 137-42. PMID 1765644 DOI: 10.1016/0022-1759(91)90319-B  0.406
1990 McClinton D, Stafford J, Brents L, Bender TP, Kuehl WM. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Molecular and Cellular Biology. 10: 705-10. PMID 2405253 DOI: 10.1128/mcb.10.2.705-710.1990  0.386
1990 Catron KM, Toth CR, Purkerson J, Isakson P, Bender TP. Constitutive and cell cycle regulated expression of c-myc mRNA is related to the state of differentiation in murine B-lymphoid tumors. Current Topics in Microbiology and Immunology. 166: 197-202. PMID 2073799 DOI: 10.1007/978-3-642-75889-8_25  0.415
1988 Kuehl WM, Bender TP, Stafford J, McClinton D, Segal S, Dmitrovsky E. Expression and function of the c-myb oncogene during hematopoietic differentiation. Current Topics in Microbiology and Immunology. 141: 318-23. PMID 3063446 DOI: 10.1007/978-3-642-74006-0_42  0.346
1988 Bender TP, Catron KM, Kuehl WM, Thompson CB. Sense and anti-sense transcription in the murine c-myb attenuator region. Current Topics in Microbiology and Immunology. 141: 324-9. PMID 2463898 DOI: 10.1007/978-3-642-74006-0_43  0.448
1987 Bender TP, Thompson CB, Kuehl WM. Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science (New York, N.Y.). 237: 1473-6. PMID 3498214 DOI: 10.1126/Science.3498214  0.413
Low-probability matches (unlikely to be authored by this person)
1986 Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature. 322: 748-50. PMID 3528861 DOI: 10.1038/322748A0  0.296
2020 Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, Qi L, Gong CC, Li XN, Barres BA, Bender TP, et al. Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth. Cell. PMID 31983537 DOI: 10.1016/J.Cell.2019.12.024  0.291
2018 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. Abstract 702: IMLEC: A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 Immunology. DOI: 10.1158/1538-7445.Am2018-702  0.29
2016 Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb. Cell. 165: 1027. PMID 27153500 DOI: 10.1016/J.Cell.2016.04.056  0.287
1986 Bender TP, Kuehl WM. Murine myb protooncogene mRNA: cDNA sequence and evidence for 5' heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. 83: 3204-8. PMID 3010282 DOI: 10.1073/Pnas.83.10.3204  0.286
2019 Dziegielewski J, Bońkowska MA, Poniecka EA, Heo J, Du K, Crittenden RB, Bender TP, Brautigan DL, Larner JM. Deletion of the SAPS1 subunit of protein phosphatase 6 in mice increases radiosensitivity and impairs the cellular DNA damage response. Dna Repair. 85: 102737. PMID 31751917 DOI: 10.1016/J.Dnarep.2019.102737  0.273
1986 Bender TP, Kuehl WM. Structure and expression of c-myb protooncogene mRNA in murine B-cells. Current Topics in Microbiology and Immunology. 132: 153-8. PMID 3491735 DOI: 10.1007/978-3-642-71562-4_22  0.259
2019 Jayappa KD, Gordon VL, Cios KJ, Morris CG, Arora PC, Bender TP, Williams ME, Portell CA, Weber MJ. Abstract 3031: Diverse microenvironmental agonists promote a multi drug tolerant persister phenotype CLL and MCL Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3031  0.259
2011 Bender TP, Gonda TJ, Frampton J, Ness SA, Ramsay RG. Professor Alan M Gewirtz (1949–2010) Oncogene. 30: 2187-2187. DOI: 10.1038/Onc.2011.78  0.255
2007 Greenberg ME, Bender TP. Identification of newly transcribed RNA. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 4.10. PMID 18265405 DOI: 10.1002/0471142727.Mb0410S78  0.22
2023 Jayappa KD, Tran B, Gordon VL, Morris CG, Saha S, Farrington CC, O'Connor CM, Zawacki KP, Isaac KM, Kester M, Bender TP, Williams ME, Portell CA, Weber MJ, Narla G. PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis. The Journal of Clinical Investigation. PMID 37166997 DOI: 10.1172/JCI155938  0.193
1986 Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S. A transfected c-myc oncogene inhibits mouse erythroleukemic differentiation. Current Topics in Microbiology and Immunology. 132: 327-30. PMID 3466771 DOI: 10.1007/978-3-642-71562-4_48  0.185
2021 Jayappa K, Gordon VL, Morris CG, Wilson B, Shetty BD, Cios KJ, Arora PC, Isaac K, Saha S, Bender TP, Williams ME, Portell C, Weber MJ. Extrinsic Interactions in the Microenvironment In Vivo Activate an Antiapoptotic Multidrug-Resistant Phenotype in CLL. Blood Advances. PMID 34432864 DOI: 10.1182/bloodadvances.2020003944  0.175
2022 Kim KB, Kabra A, Kim DW, Xue Y, Huang Y, Hou PC, Zhou Y, Miranda LJ, Park JI, Shi X, Bender TP, Bushweller JH, Park KS. KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer. Science Advances. 8: eabl4618. PMID 35171684 DOI: 10.1126/sciadv.abl4618  0.168
2010 Morse GE, Paton AS, Lough A, Bender TP. Chloro boron subphthalocyanine and its derivatives: dyes, pigments or somewhere in between? Dalton Transactions (Cambridge, England : 2003). 39: 3915-22. PMID 20372716 DOI: 10.1039/B922199A  0.16
2007 Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb Cell. 131: 146-159. PMID 17923094 DOI: 10.1016/j.cell.2007.07.021  0.154
1998 Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ. Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells* * This work was supported by Grants NIH-RO-1-65622-04 (to R.J.S.), HD-25719 (to M.A.S.), GM-55985 and CA-44579 (to T.P.B.), and CA-65746 (to R.K.). Endocrinology. 139: 4164-4174. PMID 28200164 DOI: 10.1210/endo.139.10.6229  0.134
2024 Farac NF, Lough AJ, Bender TP. Bulking Up the Bay-Position Substituents Enables Enhanced Selectivity of -Symmetric Boron Subphthalocyanine-Subnaphthalocyanine Hybrids. Precision Chemistry. 2: 161-181. PMID 38665332 DOI: 10.1021/prechem.4c00012  0.12
2014 Roxin Á, Chen J, Paton AS, Bender TP, Zheng G. Modulation of reactive oxygen species photogeneration of bacteriopheophorbide a derivatives by exocyclic E-ring opening and charge modifications. Journal of Medicinal Chemistry. 57: 223-37. PMID 24328124 DOI: 10.1021/Jm401538H  0.107
2012 Sepehrifard A, Kamino BA, Bender TP, Morin S. Siliconized triarylamines as redox mediator in dye-sensitized solar cells. Acs Applied Materials & Interfaces. 4: 6211-5. PMID 23113755 DOI: 10.1021/Am301812D  0.101
2022 Keller TCS, Lechauve C, Keller AS, Broseghini-Filho GB, Butcher JT, Askew Page HR, Islam A, Tan ZY, DeLalio LJ, Brooks S, Sharma P, Hong K, Xu W, Padilha AS, Ruddiman CA, ... ... Bender TP, et al. Endothelial alpha globin is a nitrite reductase. Nature Communications. 13: 6405. PMID 36302779 DOI: 10.1038/s41467-022-34154-3  0.095
2015 Bonnier C, Bender TP. Ring Opening Reactions through C-O Bond Cleavage Uniquely Adding Chemical Functionality to Boron Subphthalocyanine. Molecules (Basel, Switzerland). 20: 18237-45. PMID 26457699 DOI: 10.3390/Molecules201018237  0.077
2018 Dang JD, Josey DS, Dang MT, Bender TP. Phenoxy-(Chloro) -Boron Subnaphthalocyanines: Alloyed Mixture, Electron-Accepting Functionality, and Enhanced Solubility for Bulk Heterojunction Organic Photovoltaics. Acs Omega. 3: 2093-2103. PMID 31458517 DOI: 10.1021/acsomega.7b01892  0.073
2010 Morse GE, Maka JF, Lough AJ, Bender TP. Bromido(dodecafluorosubphthalo-cyaninato)boron(III). Acta Crystallographica. Section E, Structure Reports Online. 66: o3057-8. PMID 21589368 DOI: 10.1107/S1600536810041863  0.069
2015 Josey DS, Castrucci JS, Dang JD, Lessard BH, Bender TP. Evaluating thiophene electron-donor layers for the rapid assessment of boron subphthalocyanines as electron acceptors in organic photovoltaics: solution or vacuum deposition? Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. 16: 1245-50. PMID 25765007 DOI: 10.1002/Cphc.201402751  0.068
1984 Taylor SI, Schroer JA, Marcus-Samuels B, McElduff A, Bender TP. Binding of insulin to its receptor impairs recognition by monoclonal anti-insulin antibodies. Diabetes. 33: 778-84. PMID 6378700 DOI: 10.2337/Diab.33.8.778  0.064
2011 Paton AS, Lough AJ, Bender TP. (4-Cyano-phenolato)(subphthalocyaninato)boron. Acta Crystallographica. Section E, Structure Reports Online. 67: o505-6. PMID 21523157 DOI: 10.1107/S1600536811000869  0.064
2014 Morse GE, Gantz JL, Steirer KX, Armstrong NR, Bender TP. Pentafluorophenoxy boron subphthalocyanine (F5BsubPc) as a multifunctional material for organic photovoltaics. Acs Applied Materials & Interfaces. 6: 1515-24. PMID 24372192 DOI: 10.1021/Am404179Z  0.064
2010 Paton AS, Lough AJ, Bender TP. (4-Acetyl-phenolato)(subphthalo-cyaninato)boron(III). Acta Crystallographica. Section E, Structure Reports Online. 66: o3246. PMID 21589533 DOI: 10.1107/S1600536810046003  0.062
2012 Morse GE, Bender TP. Aluminum chloride activation of chloro-boronsubphthalocyanine: a rapid and flexible method for axial functionalization with an expanded set of nucleophiles. Inorganic Chemistry. 51: 6460-7. PMID 22642220 DOI: 10.1021/Ic2016935  0.061
2023 Mills HA, Rahman S, Zigelstein R, Xu H, Varju BR, Bender TP, Wilson MWB, Seferos DS. Sequence-Defined Conjugated Oligomers in Donor-Acceptor Dyads. Journal of the American Chemical Society. PMID 37862238 DOI: 10.1021/jacs.3c06923  0.061
2021 Szawiola AM, Lessard BH, Raboui H, Bender TP. Use of Piers-Rubinsztajn Chemistry to Access Unique and Challenging Silicon Phthalocyanines. Acs Omega. 6: 26857-26869. PMID 34693107 DOI: 10.1021/acsomega.1c02738  0.06
2010 Helander MG, Morse GE, Qiu J, Castrucci JS, Bender TP, Lu ZH. Pentafluorophenoxy boron subphthalocyanine as a fluorescent dopant emitter in organic light emitting diodes. Acs Applied Materials & Interfaces. 2: 3147-52. PMID 20961135 DOI: 10.1021/Am100632Y  0.059
2013 Kamino BA, Bender TP. Modified boron subphthalocyanines with stable electrochemistry and tuneable bandgaps. Dalton Transactions (Cambridge, England : 2003). 42: 13145-50. PMID 23880986 DOI: 10.1039/C3Dt50615K  0.059
2012 Paton AS, Lough AJ, Bender TP. Sulfonate pseudohalides of boron subphthalocyanine. Acta Crystallographica. Section C, Crystal Structure Communications. 68: o459-64. PMID 23124463 DOI: 10.1107/S0108270112040425  0.058
2020 Bannerman AD, Davenport Huyer L, Montgomery M, Zhao N, Velikonja C, Bender TP, Radisic M. Elastic Biomaterial Scaffold with Spatially Varying Adhesive Design. Advanced Biosystems. e2000046. PMID 32567253 DOI: 10.1002/adbi.202000046  0.056
2020 Mizrahi A, Bukuroshi E, Vestfrid J, Bender TP, Gross Z. Axial/Peripheral Chloride/Fluoride-Substituted Boron Subphthalocyanines as Electron Acceptors. Inorganic Chemistry. PMID 32077690 DOI: 10.1021/Acs.Inorgchem.9B03529  0.055
2020 Mizrahi A, Bukuroshi E, Vestfrid J, Bender TP, Gross Z. Axial/Peripheral Chloride/Fluoride-Substituted Boron Subphthalocyanines as Electron Acceptors. Inorganic Chemistry. PMID 32077690 DOI: 10.1021/Acs.Inorgchem.9B03529  0.055
2018 Sampson KL, Jiang X, Bukuroshi E, Dovijarski A, Raboui H, Bender TP, Kadish KM. A Comprehensive Scope of Peripheral and Axial Substituent Effect on the Spectroelectrochemistry of Boron Subphthalocyanines. The Journal of Physical Chemistry. A. PMID 29672045 DOI: 10.1021/Acs.Jpca.8B02023  0.054
2013 Lessard BH, Bender TP. Boron subphthalocyanine polymers by facile coupling to poly(acrylic acid-ran-styrene) copolymers synthesized by nitroxide-mediated polymerization and the associated problems with autoinitiation. Macromolecular Rapid Communications. 34: 568-73. PMID 23386322 DOI: 10.1002/Marc.201200787  0.054
2013 Lee KH, Leem DS, Castrucci JS, Park KB, Bulliard X, Kim KS, Jin YW, Lee S, Bender TP, Park SY. Green-sensitive organic photodetectors with high sensitivity and spectral selectivity using subphthalocyanine derivatives. Acs Applied Materials & Interfaces. 5: 13089-95. PMID 24274372 DOI: 10.1021/Am404122V  0.054
2018 Raboui H, Lough AJ, Szawiola AM, Bender TP. Versatile Synthesis of Siloxy Silicon Tetrabenzotriazacorroles and Insight into the Mode of Macrocycle Formation. Inorganic Chemistry. PMID 29664290 DOI: 10.1021/acs.inorgchem.8b00181  0.049
2015 Dang JD, Fulford MV, Kamino BA, Paton AS, Bender TP. Process for the synthesis of symmetric and unsymmetric oxygen bridged dimers of boron subphthalocyanines (μ-oxo-(BsubPc)2s). Dalton Transactions (Cambridge, England : 2003). 44: 4280-8. PMID 25632928 DOI: 10.1039/C4Dt02624A  0.049
2016 Virdo JD, Lough AJ, Bender TP. Redetermination of the crystal structure of boron subphthalocyanine chloride (Cl-BsubPc) enabled by slow train sublimation. Acta Crystallographica. Section C, Structural Chemistry. 72: 297-307. PMID 27045180 DOI: 10.1107/S2053229616003491  0.047
2015 Castrucci JS, Josey DS, Thibau E, Lu ZH, Bender TP. Boron Subphthalocyanines as Triplet Harvesting Materials within Organic Photovoltaics. The Journal of Physical Chemistry Letters. 6: 3121-5. PMID 26267212 DOI: 10.1021/Acs.Jpclett.5B01254  0.047
2018 Sampson KL, Jiang X, Bukuroshi E, Dovijarski A, Raboui H, Bender TP, Kadish KM. Correction to "A Comprehensive Scope of Peripheral and Axial Substituent Effect on the Spectroelectrochemistry of Boron Subphthalocyanines". The Journal of Physical Chemistry. A. PMID 30215521 DOI: 10.1021/Acs.Jpca.8B08331  0.046
2010 Paton AS, Lough AJ, Bender TP. (4-Nitro-phenolato)(subphthalo-cyaninato)boron(III). Acta Crystallographica. Section E, Structure Reports Online. 67: o57. PMID 21522767 DOI: 10.1107/S1600536810050580  0.046
2012 Fulford MV, Lough AJ, Bender TP. The first report of the crystal structure of non-solvated μ-oxo boron subphthalocyanine and the crystal structures of two solvated forms. Acta Crystallographica. Section B, Structural Science. 68: 636-45. PMID 23165600 DOI: 10.1107/S0108768112037184  0.045
2011 Kamino BA, Grande JB, Brook MA, Bender TP. Siloxane-triarylamine hybrids: discrete room temperature liquid triarylamines via the Piers-Rubinsztajn reaction. Organic Letters. 13: 154-7. PMID 21128649 DOI: 10.1021/Ol102607V  0.044
2019 Grant TM, Josey DS, Sampson KL, Mudigonda T, Bender TP, Lessard BH. Boron Subphthalocyanines and Silicon Phthalocyanines for Use as Active Materials in Organic Photovoltaics. Chemical Record (New York, N.Y.). PMID 30672126 DOI: 10.1002/Tcr.201800178  0.044
2019 Grant TM, McIntyre V, Vestfrid J, Raboui H, White RT, Lu ZH, Lessard BH, Bender TP. Straightforward and Relatively Safe Process for the Fluoride Exchange of Trivalent and Tetravalent Group 13 and 14 Phthalocyanines. Acs Omega. 4: 5317-5326. PMID 31459702 DOI: 10.1021/acsomega.8b03202  0.042
2012 Kamino BA, Mills B, Reali C, Gretton MJ, Brook MA, Bender TP. Liquid triarylamines: the scope and limitations of Piers-Rubinsztajn conditions for obtaining triarylamine-siloxane hybrid materials. The Journal of Organic Chemistry. 77: 1663-74. PMID 22220839 DOI: 10.1021/Jo2020906  0.04
2011 Morse GE, Castrucci JS, Helander MG, Lu ZH, Bender TP. Phthalimido-boronsubphthalocyanines: new derivatives of boronsubphthalocyanine with bipolar electrochemistry and functionality in OLEDs. Acs Applied Materials & Interfaces. 3: 3538-44. PMID 21812440 DOI: 10.1021/Am200758W  0.04
2010 Paton AS, Morse GE, Maka JF, Lough AJ, Bender TP. (Dodecafluorosubphthalocyaninato)(4-methylphenolato)boron(III). Acta Crystallographica. Section E, Structure Reports Online. 66: o3059. PMID 21589369 DOI: 10.1107/S1600536810042716  0.039
2022 Holst DP, Friederich P, Aspuru-Guzik A, Bender TP. Updated Calibrated Model for the Prediction of Molecular Frontier Orbital Energies and Its Application to Boron Subphthalocyanines. Journal of Chemical Information and Modeling. PMID 35171589 DOI: 10.1021/acs.jcim.1c01048  0.038
2016 Castrucci JS, Garner RK, Dang JD, Thibau E, Lu ZH, Bender TP. Characterization of μ-oxo-(BsubPc)2 in Multiple Organic Photovoltaic Device Architectures: Comparing Against and Combining with Cl-BsubPc. Acs Applied Materials & Interfaces. PMID 27548372 DOI: 10.1021/Acsami.6B06717  0.038
2015 Lessard BH, White RT, Al-Amar M, Plint T, Castrucci JS, Josey DS, Lu ZH, Bender TP. Assessing the potential roles of silicon and germanium phthalocyanines in planar heterojunction organic photovoltaic devices and how pentafluoro phenoxylation can enhance π-π interactions and device performance. Acs Applied Materials & Interfaces. 7: 5076-88. PMID 25665015 DOI: 10.1021/Am508491V  0.034
2020 Raboui H, Josey DS, Jin Y, Bender TP. Initial Engineering and Outdoor Stability Assessment of "Gray/Black" Fullerene-Free Organic Photovoltaics Based on Only Two Complementary Absorbing Materials: A Tetrabenzotriazacorrole and a Subphthalocyanine. Acs Omega. 5: 25264-25272. PMID 33043204 DOI: 10.1021/acsomega.0c03474  0.034
2015 Melville OA, Lessard BH, Bender TP. Phthalocyanine-Based Organic Thin-Film Transistors: A Review of Recent Advances. Acs Applied Materials & Interfaces. 7: 13105-18. PMID 26000612 DOI: 10.1021/Acsami.5B01718  0.033
2012 Paton AS, Morse GE, Castelino D, Bender TP. Pseudohalides of boron subphthalocyanine. The Journal of Organic Chemistry. 77: 2531-6. PMID 22316112 DOI: 10.1021/Jo202365X  0.031
2014 Lessard BH, Dang JD, Grant TM, Gao D, Seferos DS, Bender TP. Bis(tri-n-hexylsilyl oxide) silicon phthalocyanine: a unique additive in ternary bulk heterojunction organic photovoltaic devices. Acs Applied Materials & Interfaces. 6: 15040-51. PMID 25105425 DOI: 10.1021/Am503038T  0.03
1985 Bender TP, Schroer JA. Site specific monoclonal antibodies to insulin. Methods in Enzymology. 109: 704-21. PMID 2581114 DOI: 10.1016/0076-6879(85)09125-X  0.027
2012 Morse GE, Bender TP. Boron subphthalocyanines as organic electronic materials. Acs Applied Materials & Interfaces. 4: 5055-68. PMID 22979940 DOI: 10.1021/Am3015197  0.019
2012 Kamino BA, Bender TP, Klenkler RA. Hole Mobility of a Liquid Organic Semiconductor. The Journal of Physical Chemistry Letters. 3: 1002-6. PMID 26286563 DOI: 10.1021/Jz300058W  0.018
2016 Lessard BH, Lough AJ, Bender TP. Crystal structures of bis-(phen-oxy)silicon phthalocyanines: increasing π-π inter-actions, solubility and disorder and no halogen bonding observed. Acta Crystallographica. Section E, Crystallographic Communications. 72: 988-94. PMID 27555947 DOI: 10.1107/S205698901600935X  0.017
2013 Kamino BA, Bender TP. The use of siloxanes, silsesquioxanes, and silicones in organic semiconducting materials. Chemical Society Reviews. 42: 5119-30. PMID 23549525 DOI: 10.1039/C3Cs35519E  0.015
2016 Lessard BH, Dang JD, Grant TM, Gao D, Seferos DS, Bender TP. Correction to Bis(trin-hexylsilyl oxide) Silicon Phthalocyanine: A Unique Additive in Ternary Bulk Heterojunction Organic Photovoltaic Devices. Acs Applied Materials & Interfaces. PMID 27459000 DOI: 10.1021/Acsami.6B06902  0.014
Hide low-probability matches.